Reduced intestinal‐to‐diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinoma

Abstract Neoadjuvant immunochemotherapy (NAIC) achieves superior clinical benefits over neoadjuvant chemotherapy (NAC) in multiple types of human cancers, including gastric adenocarcinoma (GAC). However, it is poorly understood how the malignant epithelial cells and tumor immune microenvironment (TI...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Lei Wang, Linghong Wan, Xu Chen, Peng Gao, Yongying Hou, Linyu Wu, Wenkang Liu, Shuoran Tian, Mengyi Han, Shiyin Peng, Yuting Tan, Yuwei Pan, Yuanfeng Ren, Jinyang Li, Haihui Wen, Qin Liu, Mengsi Zhang, Tao Wang, Zhong‐Yi Qin, Junyu Xiang, Dongfeng Chen, Xianfeng Li, Shu‐Nan Wang, Chuan Chen, Mengxia Li, Fan Li, Zhenning Wang, Bin Wang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-11-01
Serie:	MedComm
Soggetti:	gastric adenocarcinoma immunochemotherapy Lauren's classification neoadjuvant therapy tumor immune microenvironment
Accesso online:	https://doi.org/10.1002/mco2.762
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!